$167.86
2.38% yesterday
Nasdaq, Nov 15, 10:00 pm CET
ISIN
US44930G1076
Symbol
ICUI

ICU Medical, Inc. Target price 2024 - Analyst rating & recommendation

ICU Medical, Inc. Classifications & Recommendation:

Buy
57%
Hold
43%

ICU Medical, Inc. Price Target

Target Price $191.60
Price $167.86
Potential
Number of Estimates 5
5 Analysts have issued a price target ICU Medical, Inc. 2025 . The average ICU Medical, Inc. target price is $191.60. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 7 analysts: 4 Analysts recommend ICU Medical, Inc. to buy, 3 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the ICU Medical, Inc. stock has an average upside potential 2025 of . Most analysts recommend the ICU Medical, Inc. stock at Purchase.

Sales and Margin forecast 2024, 2025 & 2026

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Revenue Billion $ 2.26 2.31
0.76% 2.22%
EBITDA Margin 12.85% 15.60%
20.09% 21.35%
Net Margin -1.33% -4.86%
60.15% 264.89%

6 Analysts have issued a sales forecast ICU Medical, Inc. 2024 . The average ICU Medical, Inc. sales estimate is

$2.3b
Unlock
. This is
1.25% lower
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$2.3b 0.52%
Unlock
, the lowest is
$2.3b 2.23%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2023 $2.3b 0.76%
2024
$2.3b 2.22%
Unlock
2025
$2.4b 4.18%
Unlock
2026
$2.5b 3.74%
Unlock

6 Analysts have issued an ICU Medical, Inc. EBITDA forecast 2024. The average ICU Medical, Inc. EBITDA estimate is

$360m
Unlock
. This is
39.87% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$362m 40.53%
Unlock
, the lowest is
$358m 39.05%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2023 $290m 19.18%
2024
$360m 24.08%
Unlock
2025
$409m 13.43%
Unlock
2026
$451m 10.36%
Unlock

EBITDA Margin

2023 12.85% 20.09%
2024
15.60% 21.35%
Unlock
2025
16.99% 8.91%
Unlock
2026
18.08% 6.42%
Unlock

4 ICU Medical, Inc. Analysts have issued a net profit forecast 2024. The average ICU Medical, Inc. net profit estimate is

$-112m
Unlock
. This is
0.44% lower
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$-83.7m 25.17%
Unlock
, the lowest is
$-125m 12.04%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2023 $-30.1m 60.45%
2024
$-112m 273.17%
Unlock
2025
$-27.1m 75.89%
Unlock
2026
$34.8m 228.52%
Unlock

Net Margin

2023 -1.33% 60.15%
2024
-4.86% 264.89%
Unlock
2025
-1.13% 76.75%
Unlock
2026
1.39% 223.01%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 & 2026

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Earnings Per Share $ -1.23 -4.59
60.45% 273.17%
P/E negative
EV/Sales 2.36

4 Analysts have issued a ICU Medical, Inc. forecast for earnings per share. The average ICU Medical, Inc. <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

$-4.59
Unlock
. This is
0.44% lower
Unlock
than earnings per share in the financial year 2023. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is
$-3.42 25.16%
Unlock
, the lowest is
$-5.12 12.04%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2023 $-1.23 60.45%
2024
$-4.59 273.17%
Unlock
2025
$-1.11 75.82%
Unlock
2026
$1.42 227.93%
Unlock

P/E ratio

Current -36.75 47.42%
2024
-36.57 0.49%
Unlock
2025
-151.68 314.77%
Unlock
2026
118.00 177.80%
Unlock

Based on analysts' sales estimates for 2024, the ICU Medical, Inc. stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of

and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 2.33 50.32%
2024
2.36 1.44%
Unlock
2025
2.27 4.01%
Unlock
2026
2.19 3.60%
Unlock

P/S ratio

Current 1.76 99.89%
2024
1.78 1.26%
Unlock
2025
1.71 4.01%
Unlock
2026
1.65 3.61%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today